Store
Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
Publication Date: June 12, 2025
Tags: Blood Banking, Cardiovascular Disease, Diagnostics Market Research, Genetic Diseases, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, IVD, Market Share, Market Size, Oncology and Cancer, POC, Point of Care, Respiratory Diseases, Test Categories
Pages: 460
SKU: 25-071KA
Kalorama Information’s new report, Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025, provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays—diagnostic tests that detect target analytes via antibody-antigen interactions—are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling the detection of proteins, hormones, drugs, and infectious agents.
The global immunoassay market continues to expand, driven by advances in automation, miniaturization, multiplexing, and biomarker discovery. Despite being a mature technology, immunoassays are evolving rapidly to meet modern healthcare needs—from central labs to self-testing applications.
Market Segmentation
By Setting
- Centralized Lab-Based Immunoassays:
- Used in core labs for diagnostics, monitoring, and screening.
- Market Sales: Major contributors include infectious diseases, cardiac markers, and tumor markers.
- Top segments covered:
- Infectious Disease
- Cardiac Markers
- Metabolic Disorders & Hormones
- Tumor Markers
- Autoimmune & Allergy Testing
- Point-of-Care (POC) Immunoassays:
- Includes lateral flow and other rapid tests in hospitals, clinics, retail settings, and self-testing.
- Rapidly growing due to ease of use and decentralized access.
- Top segments covered:
- Infectious Disease
- Hormone/Fertility
- Cardiac Markers
- Oncology & FOBT
- Toxicology
Breakout By Disease Category
- Infectious Disease: Largest and most diverse segment; includes tests for HIV, hepatitis, MRSA, STDs, COVID-19, and TORCH.
- Cardiac Markers: Strong growth from heart failure and acute care testing.
- Hormones & Fertility: High usage in both labs and POC; includes reproductive and thyroid hormones.
- Oncology/Tumor Markers: Focus on PSA, CEA, CA-125, AFP with lab-based dominance.
- Toxicology & Drug Monitoring: Used in pain management, emergency medicine, and substance abuse programs.
- Autoimmune & Allergy: Emerging targets and expanded panels for systemic diseases.
- Genetic Testing: Includes prenatal screening and gene expression profiling via immunoassay platforms.
- Other Emerging Areas: Alzheimer’s disease, gastrointestinal disorders, transplant medicine, and women’s health (e.g., preeclampsia).
Analysis of Geographic Trends
- Developed Markets:
- North America and Western Europe dominate due to high healthcare infrastructure and adoption of advanced diagnostics.
- Developed Asia Pacific also plays a key role.
- Emerging Markets:
- Immunoassays are key to expanding access in Latin America, Eastern Europe, Southeast Asia, and Africa, where centralized diagnostics are limited.
- Lateral flow and self-testing are critical tools in resource-limited settings.
Scope and Methodology
This report presents the global immunoassay market in U.S. dollars, covering the years 2024 through 2029. It analyzes a wide range of immunoassay technologies, from high-throughput lab instruments to manual point-of-care (POC) tests, including rapid immunochromatographic or lateral flow formats.
The primary focus is on developed regions—North America, Western Europe, and developed Asia-Pacific—while also recognizing the importance of POC testing in expanding diagnostic access in underserved areas.
Market data reflects manufacturer revenue rather than retail prices or reimbursements. Segment values generally align with test volumes, as instrument costs are often bundled into per-test pricing.
A blend of primary and secondary research underpins the report’s findings. Secondary sources included public and proprietary databases, industry reports, regulatory filings, company publications, and peer-reviewed journals. These sources provided context, competitor identification, and strategic insights.
To validate and deepen the research, Kalorama conducted over 30 interviews with industry experts such as executives, product and marketing leaders, consultants, healthcare professionals, and government representatives. These interviews provided qualitative insights into market dynamics and trends.
Additional outreach to companies yielded specific figures on revenue, market share, and product performance. All data were verified against multiple sources and, when possible, triangulated using public disclosures, proprietary insights, and expert feedback.
Market sizing and forecasts are based on 2024 as the base year, with projections through 2029 supported by historical trends, demographic shifts, technological advances, and global market expansion. Competitive analysis reflects the landscape in 2024, with forward-looking trends identified for subsequent years
Chapter 1: Executive Summary
Overview
Scope and Methodology
Market Overview
- Table 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
- Figure 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
- Figure 1-2: Global Immunoassay Market Share, 2024-2029 ($ million) [Lab-based, POC-based]
Competitive Summary
Chapter 2: Introduction
History and Future of Immunoassays
Immunoassay Technology Continues to Evolve
Chapter 3: Technology, Trends, and Innovations
Overview – Immunoassays
- Table 3-1: Immunoassay Sensitivity, by Technology Type and Setting (Lab, POC) [CLIA, ELISA, FIA, IHC, LFIA, RIA]
Chemiluminescent Immunoassay (CLIA)
Enzyme-Linked Immunosorbent Assay (ELISA)
Fluoroimmunoassay (FIA)
Immunohistochemistry (IHC)
Lateral Flow Immunoassay (LFIA)
Radioimmunoassay (RIA)
Western Blotting
Immunoassay Technology Innovations and Emerging Trends
Overview – Instrument Platforms
Microtiter Plate-Based Immunoassays and Automation
Automation in Immunoassays
Platform Innovations: Miniaturization, Microfluidics, and Multiplexing
Point-of-Care (POC) and Miniaturized Devices
Lab-on-a-Chip (LOC) and Biochips
Case Example: Veravas VeraBIND Technology
- Table 3-2: Selected Immunoassay Technologies
Specimen Types
Blood
Urine
Saliva
- Table 3-3: Selected Companies with Saliva or Oral-Fluid Collection Devices
Chapter 4: Market Segment by Setting
Centralized Laboratories
- Table 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
- Figure 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
- Figure 4-2: Global Lab-based Immunoassay Market Distribution, by Application Segment, 2024 (%) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
Companies Marketing to Centralized Laboratories
- Table 4-2: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide
Rapid and Point-of-Care Testing
- Table 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Figure 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Figure 4-4: Global POC-based Immunoassay Market Distribution, by Application, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology, Toxicology, Other]
POC Testing in Hospitals
Physician’s Office Laboratories and Clinics
Retail Clinics
Other Professional POC Testing
Self-Testing
Companies Marketing Immunoassay for POC Testing
- Table 4-4: Selected Companies Marketing Immunoassay and/or Lateral Flow Tests for POC Worldwide
Chapter 5: Immunoassay Diagnostic Market Activity by Application
- Table 5-1: Immunoassay Market Disease Categories
Allergy
- Figure 5-1: Global Allergy Immunoassay Market, 2024-2029 ($ million)
- Table 5-2: Selected Companies Marketing Immunoassays for Allergy Diagnostics
Autoimmune Disease
- Figure 5-2: Global Autoimmune Disease Immunoassay Market, 2024-2029 ($ million)
- Table 5-3: Selected Autoantibodies Detected by Autoimmune Immunoassays
Cardiac Markers
- Figure 5-3: Global Cardiac Marker Immunoassay Market, 2024-2029 ($ million)
- Table 5-4: Selected Cardiac Marker Immunoassays
- Table 5-5: Selected Cardiac Marker Innovations
Genetic Testing
- Figure 5-4: Global Genetic Immunoassay Market, 2024-2029 ($ million)
Infectious Disease
- Figure 5-5: Global Infectious Disease Immunoassay Market, 2024-2029 ($ million)
Lab-based Infectious Disease Immunoassays
- Table 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
- Figure 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
- Figure 5-7: Global Lab-based Infectious Disease Immunoassay Market Share, 2024 (%) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
Blood Screening
- Table 5-7: Selected Infectious Disease Immunoassays
- Table 5-8: Selected Companies Marketing Immunoassays for Infectious Disease
Hepatitis
Lyme Disease
Rapid and POC Testing
Retroviral
Sexually Transmitted Diseases
ToRCH
COVID-19
- Table 5-9: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
Other Infectious Diseases
Metabolic Disorders and Other Hormones
- Figure 5-8: Global Metabolic and Hormone Disorder Immunoassay Market, 2024-2029 ($ million)
- Table 5-10: Selected Metabolic and Other Hormone Immunoassays
Fertility/Pregnancy/Reproductive Hormones
- Table 5-11: Selected Fertility and Reproductive Hormone Immunoassays
Thyroid
- Table 5-12: Selected Thyroid Hormone Immunoassays
Oncology – Tumor Markers
- Figure 5-9: Global Oncology Immunoassay Market, 2024-2029 ($ million)
Lab-based Oncology Immunoassays
- Table 5-13: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
- Figure 5-10: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
- Figure 5-11: Global Lab-based Tumor Marker Immunoassay Market Share, 2024 (%) [AFP, CA-125, CEA, PSA, Others]
- Table 5-14: Selected Companies Marketing Immunoassays for Tumor Markers
- Table 5-15: Selected Companies Marketing Metabolic Immunoassays
Toxicology
- Figure 5-12: Global Toxicology Marker Immunoassay Market, 2024-2029 ($ million)
Drugs of Abuse
- Table 5-16: Selected Drugs of Abuse Immunoassays
Therapeutic Drug Monitoring
- Table 5-17: Selected Therapeutic Drug Monitoring Immunoassays
Other Disease Categories in Immunoassay Disease Market
- Figure 5-13: Other Immunoassay Market, 2024-2029 ($ million)
- Table 5-18: Selected Other Immunoassays
Chapter 6: Market Opportunities and Issues for Immunoassays
Immunoassay Market – Overview
Immunoassay Market Drivers and Challenges
Drivers
New and Emerging Areas of Immunoassay Innovation
Gastrointestinal Disorders
- Table 6-1: Selected Inflammatory Bowel Disease Test Innovations
Transplant Management
- Table 6-2: Selected Immunoassays for Transplant Medicine
Preeclampsia
- Table 6-3: Selected Women’s Health Innovations
Alzheimer’s Disease
- Table 6-4: Selected Innovations for Alzheimer’s Disease Immunoassays
- Table 6-5: Selected Immunoassay Innovations
Emerging International Markets
- Table 6-6: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays
Lab-Developed Tests
Staffing Shortages
Outlook for Immunoassays
Chapter 7: Immunoassay Market Analysis
Market Overview and Market Segments
- Table 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
- Figure 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
- Figure 7-2: Global Immunoassay Market Segment Share, by Laboratory Setting, 2024 (%) [Lab-based, POC-based]
Central Lab-based Immunoassay Market
- Table 7-2: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
- Figure 7-3: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
Point of Care/Rapid Test Immunoassays by Disease Category
- Table 7-3: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Figure 7-4: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
- Figure 7-5 Global POC Immunoassay Market Analysis, by Disease Category Market Share, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
Immunoassay Market by Technology Type
- Table 7-4: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
- Figure 7-6: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
- Table 7-5: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
- Figure 7-7: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
Competitive Analysis
- Table 7-6: Global Immunoassay Market Analysis, by Competitor Revenues ($ million) and Market Share (%), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
- Figure 7-8: Global Immunoassay Market Analysis, by Competitor Revenues ($ million), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
- Figure 7-9: Global Immunoassay Market Analysis, by Competitor Market Share, 2024 (%) [Abbott, Becton Dickinson, Bio-Rad, bioMérieux, Bruker – CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
Immunoassay Market by Geographic Regions
- Table 7-7: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
- Figure 7-10: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
- Figure 7-11: Immunoassay Market Share, by Geographic Region, 2024 (%) [Asia Pacific, Europe, North America, Rest of World]
North America
Europe
- Table 7-8: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
- Figure 7-12: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
- Figure 7-13: Immunoassay Market Share, by European Geographic Region, 2024 (%) [France, Germany, Italy, Spain, United Kingdom, Others]
Asia Pacific
- Table 7-9: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
- Figure 7-14: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
- Figure 7-15: Immunoassay Market Share, by Asia Pacific Geographic Region, 2024 (%) [China, India, Japan, Others]
Rest of World
- Table 7-10: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
- Figure 7-16: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
- Figure 7-17: Immunoassay Market Share, by Rest of World Geographic Region, 2024 (%) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
Chapter 8: Company Profiles
1 Step Detect Associates, LLC
- Table 8-1: 1-Step Detect Associates Corporate Summary
Company Overview
Products
Abbott Laboratories
- Table 8-2: Abbott Corporate Summary
Company Overview
Products
Performance Review
- Table 8-3: Abbott Revenues, 2023-2024 ($millions)
Abingdon Health, Ltd.
- Table 8-4: Abingdon Health Corporate Summary
Company Overview
Products
Access Bio, Inc.
- Table 8-5: Access Bio Summary
Company Overview
Products
AccuBioTech Co, Ltd.
- Table 8-6: AccuBioTech Corporate Summary
Company Overview
Products
ACON Laboratories, Inc
- Table 8-7: ACON Laboratories Corporate Summary
Company Overview
Products
AESKU. DIAGNOSTICS
- Table 8-8: AESKU.DIAGNOSTICS Corporate Summary
Company Overview
Products
Aidian Oy
- Table 8-9: Aidian Corporate Summary
Company Overview
Products
Alfa Scientific Designs, Inc
- Table 8-10: Alfa Scientific Design
Company Overview
Products
American Laboratory Products Company (ALPCO)
- Table 8-11: American Laboratory Products Corporate Summary
Company Overview
Products
Anbio Biotechnology
- Table 8-12: Anbio Biotechnology Corporate Summary
Company Overview
Products
ARKRAY, Inc
- Table 8-13: ARKRAY Corporate Summary
Company Overview
Products
Arlington Scientific, Inc.
- Table 8-14: Arlington Scientific Corporate Summary
Company Overview
Products
Artron Laboratories Inc.
- Table 8-15: Artron Laboratories Corporate Summary
Company Overview
Products
Associates of Cape Cod, Inc. (ACC)
- Table 8-16: Associates of Cape Cod Corporate Summary
Company Overview
Products
Autobio Diagnostics Co., Ltd
- Table 8-17: Autobio Diagnostics Corporate Summary
Company Overview
Products
Avioq, Inc.
- Table 8-18: Avioq Corporate Summary
Company Overview
Products
Awareness Technology
- Table 8-19: Awareness Technology Corporate Summary
Company Overview
Products
Beckman Coulter, Inc
- Table 8-20: Beckman Coulter Corporate Summary
Company Overview
Products
Becton Dickinson (BD)
- Table 8-21: BD Corporate Summary
Company Overview
Products
Company Financials
- Table 8-22: BD Corporation Revenue, 2023-2024 ($ million)
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Table 8-23: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
Company Overview
Products
Bhat Bio-Tech India Private Ltd. (BBI)
- Table 8-24: Bhat Bio-Tech India Private Corporate Summary
Company Overview
Products
BioCheck, Inc.
- Table 8-25: BioCheck Corporate Summary
Company Overview
Products
Biohit Oyj (Biohit Healthcare)
- Table 8-26: Biohit Oyj Corporate Summary
Company Overview
Products
bioLytical Laboratories
- Table 8-27: bioLytical Laboratories Corporate Summary
Company Overview
Products
BioMedomics, Inc.
- Table 8-28: BioMedomics Corporate Summary
Company Overview
Products
Biomerica
- Table 8-29: Biomerica Summary
Company Overview
Products
Company Financials
- Table 8-30: Biomerica Corporation Revenue, 2023-2024 ($ million)
bioMérieux SA
- Table 8-31: bioMérieux SA Corporate Summary
Company Overview
Products
Company Financials
- Table 8-32: bioMérieux Revenues, 2023-2024 (€ millions)
BioPorto Diagnostics
- Table 8-33: BioPorto Diagnostics Corporate Summary
Company Overview
Products
Company Financials
- Table 8-34: BioPorto Diagnostics Revenues, 2023-2024 (DKK millions)
Bio-Rad Laboratories Inc.
- Table 8-35: Bio-Rad Labs Corporate Summary
Company Overview
Products
Company Financials
- Table 8-36: Bio-Rad Corporation Revenue, 2023-2024 ($ million)
Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
- Table 8-37: Bioscience (Tianjin) Diagnostic Technology Corporate Summary
Company Overview
Products
Bio-Techne
- Table 8-38: Bio-Techne Corporate Summary
Company Overview
Products
Company Financials
- Table 8-39: Bio-Techne, 2023-2024 ($ million)
Biotron Diagnostics, Inc.
- Table 8-40: Biotron Diagnostics Corporate Summary
Company Overview
Products
Boditech Med Inc.
- Table 8-41: Boditech Med Corporate Summary
Company Overview
Products
Performance Review
- Table 8-42: Boditech Med Revenues 2023-2024 (KRW billion)
Boson Biotech Co. Ltd
- Table 8-43: Boson Biotech Corporate Summary
Company Overview
Products
BUHLMANN Laboratories AG
- Table 8-44: BUHLMANN Laboratories Summary
Company Overview
Products
Certest Biotec
- Table 8-45: Certest Biotec Summary
Company Overview
Products
Chembio Diagnostic Systems, Inc.
- Table 8-46: Chembio Diagnostic Corporate Summary
Company Overview
Products
Clarity Diagnostics, LLC
- Table 8-47: Clarity Diagnostics Corporate Summary
Company Overview
Products
Confirm Biosciences
- Table 8-48: Confirm Biosciences Corporate Summary
Company Overview
Products
CTK Biotech, Inc.
- Table 8-49: CTK Biotech Corporate Summary
Company Overview
Products
Diagenics Group SE
- Table 8-50: Diagenics Group Corporate Summary
Company Overview
Products
DIALAB GmbH
- Table 8-51: DIALAB Summary
Company Overview
Products
Diametra
- Table 8-52: Diametra Corporate Summary
Company Overview
Products
DiaSorin S.p.A.
- Table 8-53: DiaSorin Corporate Summary
Company Overview
Products
Company Financials
- Table 8-54: DiaSorin 2023-2024 (€ thousand)
DiaSource ImmunoAssays SA
- Table 8-55: DiaSource ImmunoAssays Corporate Summary
Company Overview
Products
DiaSys Diagnostic Systems GmbH (Mindray)
- Table 8-56: DiaSys Diagnostic Systems Corporate Summary
Company Overview
Products
Diazyme Laboratories, Inc.
- Table 8-57: Diazyme Laboratories Corporate Summary
Company Overview
Products
Dr. Fooke-Achterrath Laboratorien GmbH
- Table 8-58: Dr. Fooke-Achterrath Laboratorien Corporate Summary
Company Overview
Products
Eiken Chemical Co Ltd.
- Table 8-59: Eiken Chemical Corporate Summary
Company Overview
Products
Performance Review
- Table 8-60: Eiken Chemical Revenues, 2023-2024 (million yen)
EKF Diagnostics Holdings plc
- Table 8-61: EKF Diagnostics Corporate Summary
Company Overview
Products
ELITechGroup S.A.S.
- Table 8-62: ELITechGroup Corporate Summary
Company Overview
Products
Eurobio Scientific
- Table 8-63: Eurobio Scientific Corporate Summary
Company Overview
Products
Eurospital Spa
- Table 8-64: Eurospital Summary
Company Overview
Products
EY Laboratories
- Table 8-65: EY Laboratories Summary
Company Overview
Products
Fujirebio-US, Inc.
- Table 8-66: Fujirebio Corporate Summary
Company Overview
Products
GenBio
- Table 8-67: GenBio Corporate Summary
Company Overview
Products
Gold Standard Diagnostics
- Table 8-68: Gold Standard Diagnostics Corporate Summary
Company Overview
Products
Grifols International S.A.
- Table 8-69: Grifols International S.A. Corporate Summary
Company Overview
Products
Company Financials
- Table 8-70: Grifols Revenue, 2023-2024 (€ million)
Hemosure, Inc.
- Table 8-71: Hemosure Corporate Summary
Company Overview
Products
HYCOR Biomedical, Inc.
- Table 8-72: HYCOR Biomedical Corporate Summary
Company Overview
Products
Immuno-Mycologics, Inc.
- Table 8-73: Immuno-Mycologics Corporate Summary
Company Overview
Products
Immunosciences Lab, Inc.
- Table 8-74: Immunosciences Lab Corporate Summary
Company Overview
Products
Immunostics, Inc
- Table 8-75: Immunostics Corporate Summary
Company Overview
Products
InBios International, Inc.
- Table 8-76: InBios Corporate Summary
Company Overview
Products
JAL Innovation PTE LTD
- Table 8-77: JAL Innovation Corporate Summary
Company Overview
Products
Jant Pharmacal Corporation
- Table 8-78: Jant Pharmacal Summary
Company Overview
Products
- Mitra & Co Pvt. Ltd
- Table 8-79: J Mitra Corporate Summary
Company Overview
Products
KRONUS
- Table 8-80: KRONUS Corporate Summary
Company Overview
Products
Kypha
- Table 8-81: Kypha Corporate Summary
Company Overview
Products
Labsystems Diagnostics Oy
- Table 8-82: Labsystems Diagnostics Corporate Summary
Company Overview
Products
LamdaGen Corporation
- Table 8-83: LamdaGen Corporate Summary
Company Overview
Products
LifeSign, LLC
- Table 8-84: LifeSign Summary
Company Overview
Products
Macherey-Nagel GmbH & Co. KG
- Table 8-85: Macherey-Nagel Corporate Summary
Company Overview
Products
Medix Biochemica
- Table 8-86: Medix Biochemica Summary
Company Overview
Products
MedMira, Inc
- Table 8-87: MedMira Corporate Summary
Company Overview
Products
Performance Review
- Table 8-88: MedMira, Revenues 2023-2024 ($ thousands)
Mercodia AB
- Table 8-89: Mercodia AB Summary
Company Overview
Products
Meridian BioScience, Inc
- Table 8-90: Meridian BioScience Corporate Summary
Company Overview
Products
Monobind, Inc
- Table 8-91: Monobind Corporate Summary
Company Overview
Products
Nano-Ditech Corporation
- Table 8-92: Nano-Ditech Corporate Summary
Company Overview
Products
Nexus Dx Inc
- Table 8-93: Nexus Dx Corporate Summary
Company Overview
Products
Nova Biomedical, Corp.
- Table 8-94: Nova Biomedical Corporate Summary
Company Overview
Products
Oasis Diagnostics Corporation
- Table 8-95: Oasis Diagnostics Corporate Summary
Company Overview
Products
Operon
- Table 8-96: Operon Corporate Summary
Company Overview
Products
OPKO Health, Inc
- Table 8-97: OPKO Health Corporate Summary
Company Overview
Products
Performance Review
- Table 8-98: OPKO Health Revenues, 2023-2024 ($ million)
OraSure Technologies, Inc.
- Table 8-99: OraSure Technologies Corporate Summary
Company Overview
Products
Performance Review
- Table 8-100: OraSure Revenues, 2023-2024 ($ million)
PixCell Medical Technologies
- Table 8-101: PixCell Corporate Summary
Company Overview
Products
Polymedco, Inc
- Table 8-102: Polymedco Corporate Summary
Company Overview
Products
Precision Biosensor
- Table 8-103: Precision Biosensor Corporate Summary
Company Overview
Products
Preventis GmbH
- Table 8-104: Preventis Corporate Summary
Company Overview
Products
Princeton Biomeditech Corporation
- Table 8-105: Princeton Biomeditech Corporate Summary
Company Overview
Products
PTS Diagnostics
- Table 8-106: PTS Corporate Summary
Company Overview
Products
Qualigen, Inc.
- Table 8-107: Qualigen Corporate Summary
Company Overview
Products
Quanterix Corporation
- Table 8-108: Quanterix Corporate Summary
Company Overview
Products
QuidelOrtho Corporation
- Table 8-109: QuidelOrtho Corporate Summary
Company Overview
Products
Performance Review
- Table 8-110: QuidelOrtho Revenues, 2023-2024 ($ million)
Radiometer Medical A/S
- Table 8-111: Radiometer Medical Corporate Summary
Company Overview
Products
Response Biomedical Corp
- Table 8-112: Response Biomedical Corporate Summary
Company Overview
Products
Reszon Diagnostics International Sdn. Bhd.
- Table 8-113: Reszon Diagnostics Corporate Summary
Company Overview
Products
Revvity
- Table 8-114: Revvity Corporate Summary
Company Overview
Products
Performance Review
- Table 8-115: Revvity Revenues, 2023-2024 ($ million)
Roche Diagnostic Corporation
- Table 8-116: Roche Corporate Summary
Company Overview
Products
Performance Review
- Table 8-117: Roche Diagnostics Revenue, 2023-2024 (CHF millions)
Savyon Diagnostics Ltd.
- Table 8-118: Savyon Diagnostics Summary
Company Overview
Products
Sekisui Diagnostics LLC
- Table 8-119: Sekisui Diagnostics Corporate Summary
Company Overview
Products
Siemens Healthineers
- Table 8-120: Siemens Healthineers Corporate Summary
Company Overview
Products
Performance Review
- Table 8-121: Siemens Healthineers Revenue, 2023-2024 (€ millions)
Syntron Bioresearch, Inc.
- Table 8-122: Syntron Bioresearch Corporate Summary
Company Overview
Products
Sysmex Corporation
- Table 8-123: Sysmex Corporate Summary
Company Overview
Products
Performance Review
- Table 8-124: Sysmex Revenues, 2023-2024 (billion yen)
TECHLAB, Inc.
- Table 8-125: TECHLAB Corporate Summary
Company Overview
Products
Teco Diagnostics
- Table 8-126: Teco Diagnostics Corporate Summary
Company Overview
Products
Thermo Fisher Scientific, Inc
- Table 8-127: Thermo Fisher Scientific Corporate Summary
Company Overview
Products
Company Financials
- Table 8-128: Thermo Fisher Scientific Revenues, 2023-2024 ($ million)
Tosoh Bioscience, Inc.
- Table 8-129: Tosoh Bioscience Corporate Summary
Company Overview
Products
Company Financials
- Table 8-130: Tosoh Corporation Revenue, 2023-2024 (billion yen)
Trinity Biotech PLC
- Table 8-131: Trinity Biotech Corporate Summary
Company Overview
Products
True Diagnostics
- Table 8-132: True Diagnostics Corporate Summary
Company Overview
Products
VedaLab
- Table 8-133: VedaLab Corporate Summary
Company Overview
Products
Vircell
- Table 8-134: Vircell Corporate Summary
Company Overview
Products
WAMA Diagnostica
- Table 8-135: WAMA Diagnostica Corporate Summary
Company Overview
Products
Werfen Group
- Table 8-136: Werfen Group Corporate Summary
Company Overview
Products
Zeus Scientific, Inc.
- Table 8-137: Zeus Scientific Corporate Summary
Company Overview
Products
Related products
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
Price range: $5,000.00 through $7,500.00
The Market and Future Potential for Molecular Point-of-Care (mPOC), 11th Edition
March 7, 2024
Explore the cutting-edge world of molecular point-of-care (mPOC) diagnostic solutions with our latest report, offering a detailed analysis of the market and future growth potential from 2023-2028. mPOC technology revolutionizes diagnostic capabilities, providing enhanced sensitivity and specificity compared to traditional near-patient tests. These solutions are instrumental in critical care units, physician offices, outpatient clinics,…
Price range: $5,000.00 through $7,875.00
